Value of renal biopsy in the prognosis of liver transplantation in familial amyloid polyneuropathy ATTR Val30Met patients

被引:17
|
作者
Oguchi, Kenya [1 ]
Takei, Yo-Ichi [1 ]
Ikeda, Shu-Ichi [1 ]
机构
[1] Shinshu Univ, Sch Med, Dept Med 3, Matsumoto, Nagano 3908621, Japan
来源
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2006年 / 13卷 / 02期
关键词
amyloid; familial amyloid polyneuropathy; renal amyloidosis; transthyretin; liver transplantation;
D O I
10.1080/13506120600722662
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Liver transplantation for familial amyloid polyneuropathy (FAP) patients has been carried out worldwide and the outcomes seem to be promising. To clarify the severity of amyloid deposits on visceral organs, we evaluated the histopathological findings of biopsied renal and sural nerve specimens in 13 FAP patients with ATTR Va130Met by quantitative analysis, and compared them with the outcome of transplantation. Renal dysfunction with proteinuria seemed to correlate with the degree of amyloid deposits in glomeruli, not with that in medullary tissues. The severity of renal amyloid deposition did not consistently parallel that of myelinated nerve fiber loss in sural nerve. Three patients with proteinuria and severe amyloid deposits in glomeruli were considered to be unsuitable for transplantation. Ten patients underwent living donor liver transplantation and three resulted in unfavorable outcomes. These three had heavy amyloid deposits on renal tissues, especially in glomerular areas, but the severity of myelinated nerve fiber loss in their sural nerves was very similar to that in patients who made a good recovery. The prognosis after operation might be closely related to the severity of amyloid deposits in renal glomeruli. Renal biopsy is, therefore, recommended when determining the indications and contraindications for liver transplantation in FAP patients, although this biopsy is not routinely required.
引用
收藏
页码:99 / 107
页数:9
相关论文
共 50 条
  • [41] Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas
    Koike, Haruki
    Tanaka, Fumiaki
    Hashimoto, Rina
    Tomita, Minoru
    Kawagashira, Yuichi
    Iijima, Masahiro
    Fujitake, Junko
    Kawanami, Toru
    Kato, Takeo
    Yamamoto, Masahiko
    Sobue, Gen
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (02) : 152 - 158
  • [42] Single-centre experience of liver transplantation for familial amyloidotic polyneuropathy of non-Val30Met variants in Chinese patients
    Dai, Wing Chiu
    Chan, See Ching
    Chok, Kenneth S. H.
    Cheung, Tan To
    Sharr, William W.
    Chan, Albert C. Y.
    Fung, James Y. Y.
    Tsang, Simon H. Y.
    Fan, Sheung Tat
    Lo, Chung Mau
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2012, 19 (01): : 33 - 36
  • [43] Effect of MPO/H2O2/NO- system on nitric oxide-mediated modification of TTR amyloid and serum TTR in FAP ATTR Val30Met patients
    Liu, J. P.
    Wang, Q. Y.
    Zheng, F.
    Lu, J. H.
    Ge, P.
    Gu, Y. J.
    Sun, X. G.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (02) : 2368 - 2376
  • [44] Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met
    Dardiotis, Efthimios
    Koutsou, Pantelitsa
    Zamba-Papanicolaou, Eleni
    Vonta, Ilia
    Hadjivassiliou, Marilena
    Hadjigeorgiou, Georgios
    Cariolou, Marios
    Christodoulou, Kyproula
    Kyriakides, Theodoros
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 284 (1-2) : 158 - 162
  • [45] Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Varl30Met: A phase III, open-label study
    Yukio, Ando
    Yoshiki, Sekijima
    Konen, Obayashi
    Taro, Yamashita
    Mitsuharu, Ueda
    Yohei, Misumi
    Hiroshi, Morita
    Katsuyuki, Machii
    Makoto, Ohta
    Ami, Takata
    Shu-ichi, Ikeda
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 362 : 266 - 271
  • [46] Amyloid fibril composition type is consistent over time in patients with Val30Met (p.Val50Met) transthyretin amyloidosis
    Anan, Intissar
    Suhr, Ole B.
    Liszewska, Katarzyna
    Baranda, Jorge Mejia
    Pilebro, Bjorn
    Wixner, Jonas
    Ihse, Elisabet
    PLOS ONE, 2022, 17 (03):
  • [47] Spatial visual contrast sensitivity in liver transplanted Portuguese familial amyloidotic polyneuropathy (ATTR V30M) patients
    Beirao, Melo
    Matos, Eduada
    Reis, Rita
    Beirao, Idalina
    Costa, Paulo P.
    Torres, Paulo
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2012, 19 (03): : 152 - 155
  • [48] Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy:: ocular synthesis of mutant transthyretin
    Munar-Qués, M
    Salvá-Ladaria, L
    Mulet-Perera, P
    Solé, M
    López-Andreu, FR
    Saraiva, MJM
    AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 2000, 7 (04): : 266 - 269
  • [49] Coexistence of familial transthyretin amyloidosis ATTR Val30Met and spinocerebellar ataxia type 1 in a Japanese family - A follow-up autopsy report
    Oide, T
    Arima, K
    Yamazaki, M
    Hanyu, N
    Ikeda, S
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2004, 11 (03): : 191 - 199
  • [50] Peripheral nerve function in patients with familial amyloid polyneuropathy after liver transplantation
    Kobayashi, S
    Morita, H
    Asawa, T
    Takei, Y
    Hashimoto, T
    Ikegami, T
    Hashikura, Y
    Kawasaki, S
    Ikeda, S
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2003, 10 (01): : 17 - 24